Orange Book product · Generic (ANDA)
RIBAVIRIN
RIBAVIRIN
At a glance
Aug 12, 2014
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 12, 2014
12 yr ago
Today
Pharmaceutical detail
Active ingredient
RIBAVIRIN
Strength
200MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 202546
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of RIBAVIRIN
- 2003REBETOLBrand (NDA)
NDA 021546 · SCHERING
- 2002COPEGUSBrand (NDA)
NDA 021511 · ROCHE
- 1998REBETOLBrand (NDA)
NDA 020903 · MERCK SHARP DOHME
- 1985VIRAZOLEBrand (NDA)
NDA 018859 · BAUSCH
- 2016RIBAVIRINGeneric (ANDA)
ANDA 207366 · NAVINTA LLC
- 2009RIBAVIRINGeneric (ANDA)
ANDA 079117 · AUROBINDO PHARMA
- 2009RIBAVIRINGeneric (ANDA)
ANDA 079111 · AUROBINDO PHARMA
- 2006RIBAVIRINGeneric (ANDA)
ANDA 077743 · SANDOZ
- 2005RIBAVIRINGeneric (ANDA)
ANDA 077456 · CHARTWELL RX
- 2005RIBAVIRINGeneric (ANDA)
ANDA 077053 · HERITAGE PHARMA AVET
- 2005RIBAVIRINGeneric (ANDA)
ANDA 077094 · ZYDUS PHARMS USA
- 2005RIBAVIRINGeneric (ANDA)
ANDA 077224 · ZYDUS PHARMS USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
